



RNA Dynamics by Design: Biasing Ensembles Towards the Ligand-
Bound State**
Andrew C. Stelzer, Jeremy D. Kratz, Qi Zhang, and Hashim M. Al-Hashimi*
ange_201000814_sm_miscellaneous_information.pdf
I. Supplemental Methods…………………………………………............................S2 
a. Sample preparation and resonance assignments…………………………….S2 
b. RDC measurements and order tensor analysis……………………………....S2 
c. Measurements of resonance intensities and Kds……………………………..S2 
II. Supplemental Tables……………………………………………………………….S4 
a. Table S1……………………………………………………...………………….S4 
b. Table S2…………………………………………………………………………S6 
III. Supplemental Figures……………………………………………………….……..S7 
a. Figure S1…………………………………………………………...………………S7 
b. Figure S2…………………………………………………………...………………S8 
c. Figure S3…………………………………………………………...………………S9 
d. Figure S4……………………………………………..…………...………………S10 
IV. Supplemental References…………………………………………………………S11 
 
Supplemental Methods 
Sample preparation and resonance assignments. Uniformly 13C/15N labeled TARGC was prepared by run-off in-vitro 
transcription using synthetic double-stranded DNA containing the T7 promoter and RNA sequence of interest (Integrated DNA 
Technologies). Elongated and non-elongated TARGC constructs were purified by 15% (w/v), and 20% (w/v) denaturing 
polyacrylamide gel electrophoresis containing 8M urea and 1x TBE, respectively, followed by electroelution in 20 mM Tris 
pH 8 buffer and EtOH precipitation. The resultant RNA pellet was dissolved and exchanged into NMR buffer (15 mM sodium 
phosphate, 0.1 mM EDTA, and 25 mM NaCl at pH ~6.4) using a Centricon Ultracel YM-3 concentrator to a final 
concentration of ~0.5-1.0 mM (Millipore Corp.). All NMR samples contained 10% D2O. All experiments were conducted in 
NMR buffer at 298 K on an Avance Bruker 600 MHz NMR spectrometer equipped with a triple-resonance 5 mm cryogenic 
probe. The TARGC NMR spectra were assigned using conventional NMR methods employing  exchangeable 3D 1H-15N 
NOESY-HSQC and non-exchangeable 2D 1H-13C NOESY-HSQC, 2D HCN, 2D IP-COSY experiments. Argininamide (ARG, 
Sigma Aldrich) and Neomycin B (NEOB, MP Biomedicals) titrations were performed by sequentially adding ~2uL of 
concentrated ARG and NEOB samples to 0.1 mM TARGC and TAR-ARG, up to final ligand concentrations of 2.5 mM and 0.8 
mM, respectively. 2D HSQC spectra were collected at each titration point. 
 
RDC measurements and order tensor analysis. RDCs were measured in TARGC and EI-TARGC as previously described[1,2] 
using ~7mg/ml and ~23 mg/ml of Pf1 phage order medium3, respectively (Table S1). The RDCs measured in the two helices of 
TARGC were subjected to an order tensor analysis (Table S2).[4-6]  RDCs measured in E-AU-TARGC and E-GC-TARGC were 
normalized (L=0.66) as previously described[2]  to take into account differences in the degree of alignment arising from use of a 
slightly different Pf1 phage concentration. The normalized RDCs measured in each helix were combined in the order tensor 
analysis. Due to deviations from Watson-Crick geometry, the A22-U40 and terminal G17-C45 base-pairs were excluded from 
the analysis. The program AFORM-RDC[6] was used to estimate errors in the order tensor arising from “structural noise” and 
RDC measurement uncertainty. A-form helices were constructed using Insight II (Molecular Simulations, Inc), noting that the 
propeller twist angles had to be corrected from +15° to the standard A-form value of -15°.[6] 
 
Measurements of resonance intensities and Kds. Resonance intensities were measured and normalized to a baseline value of 
0.1 as described previously for EI-TAR and EI-TAR-ARG7. TAR-ARG Dissociation constants were calculated from the 
change in weighted average chemical shift for each titration point using the equation[8], 
    
,
 
in which [ARG]T is the total ARG concentration, [RNA]T is the RNA concentration based on UV absorbance at 260 nm, ΔδT is 
the difference in chemical shifts between the free and ligand-associated states (in ppm), dobs is the observed chemical shift (in 
ppm), and δfree is the chemical shift in the free state (in ppm). The data was fit using the Origin software (OriginLab 





Table S1. RDCs measured in EI-TARGC, TARGC-ARG, and TARGC.   
 
Residue Bond EI-TARGC TARGC-ARG TARGC 
G17 (C8H8) 18.0 NA -1.3 
G17 (N1H1) -14.6 -10.1 0.7 
G17 (C1'H1') NA NA NA 
G18 (C8H8) NA 0.0 NA 
G18 (C1'H1') NA NA NA 
G18 (N1H1) -18.5 -3.9 NA 
C19 (C5H5) NA NA -2.4 
C19 (C6H6) 11.3 NA NA 
A20 (C2H2) 25.2 8.4 2.3 
A20 (C8H8) 21.0 30.5 11.7 
A20 (C1'H1') NA NA -19.2 
G21 (C8H8) 24.5 44.7 19.4 
G21 (C1'H1') NA -48.0 -17.2 
G21 (N1H1) -20.2 -22.8 9.3 
G22 (C2H2) NA NA NA 
G22 (C8H8) 23.8 NA 20.9 
G22 (C1'H1') 2.2 NA 8.9 
G22 (N1H1) -16.5 -18.7 4.5 
U23 (C5H5) NA 37.7 -0.9 
U23 (C6H6) 3.6 38.4 5.4 
U23 (C1'H1') -4.5 37.9 0.2 
C24 (C5H5) -3.8 -6.5 -3.7 
C24 (C6H6) 0.9 6.4 1.9 
C24 (C1'H1') -5.2 -10.2 -2.9 
U25 (C5H5) -0.5 1.5 0.4 
U25 (C6H6) -1.8 -14.8 0.1 
U25 (C1'H1') -2.1 -7.3 -1.3 
G26 (C8H8) 23.2 26.9 12.4 
G26 (C1'H1') NA NA -10.9 
G26 (N1H1) NA NA 3.2 
A27 (C2H2) 20.7 33.2 12.5 
A27 (C8H8) 20.7 25.2 7.0 
A27 (C1'H1') NA -8.0 -6.5 
G28 (C8H8) NA 25.6 8.1 
G28 (C1'H1') NA -13.9 -12.0 
G28 (N1H1) NA -18.3 6.4 
C29 (C5H5) NA NA 6.1 
C29 (C6H6) 12.6 37.4 17.7 
C29 (C1'H1') NA NA NA 
U31 (C5H5) 18.0 31.3 14.3 
U31 (C6H6) 19.9 31.2 16.9 
U31 (C1'H1') -13.7 -21.5 -8.8 
U32 (C5H5) NA 25.4 10.4 
U32 (C6H6) 12.1 15.3 2.9 
U32 (C1'H1') 19.2 25.2 9.0 
C33 (C5H5) 6.0 -6.1 1.0 
C33 (C6H6) 13.2 12.1 4.1 
C33 (C1'H1') 1.0 -33.6 -8.5 
G34 (C8H8) 22.6 24.1 7.7 
G34 (C1'H1') 20.1 11.6 5.2 
G34 (N1H1) -24.9 NA 7.1 
G36 (C8H8) 25.7 46.6 21.5 
G36 (C1'H1') -11.2 NA NA 
G36 (N1H1) NA -21.5 7.8 
C37 (C5H5) 20.8 NA 20.7 
C37 (C6H6) 14.0 NA NA 
C37 (C1'H1') NA NA -8.0 
U38 (C5H5) 23.2 NA 18.8 
U38 (C6H6) NA 23.7 7.1 
U38 (C1'H1') -13.2 -20.2 -9.3 
U38 (N3H3) -11.1 -11.4 4.3 
C39 (C5H5) NA NA 13.0 
C39 (C6H6) 14.6 NA 13.5 
C39 (C1'H1') NA -38.5 NA 
C40 C6H6 15.9 NA 19.2 
C40 (C5H5) NA NA 9.6 
C40 (C1'H1') NA NA -13.1 
C41 (C5H5) 22.6 NA 10.9 
C41 (C6H6) NA NA NA 
U42 (C5H5) 22.4 37.7 16.7 
U42 (C1'H1') NA -7.3 NA 
U42 (N3H3) -14.5 -17.5 6.4 
G43 (C8H8) 15.1 26.9 14.5 
G43 (C1'H1') NA NA NA 
G43 (N1H1) NA -7.2 -2.0 
C44 (C6H6) NA NA -2.7 
C44 (C5H5) NA NA 18.5 
C45 (C6H6) NA NA -0.9 
C45 (C5H5) NA 17.8 6.7 
C45 (C1'H1') NA -16.6 -6.7 
G-21 (C8H8) 19.6 NA NA 
C+21 (C5H5) 21.8 NA NA 
 
 
Table S2. Statistics for order tensor analysis of RDCs measured in the helices of EI-TARGC and TARGC-ARG using idealized 
A-form helices as input coordinates. Shown are the number of RDCs (N) used in the order tensor determination, the root-mean-
square deviation (RMSD) and correlation coefficient (R) between measured and back-predicted values, asymmetry parameter 
(η), generalized degree of order (ϑ),internal generalized degree of order (ϑint), and inter-helical bend angle (β). Errors in ϑ, 
ϑint, η, and β are obtained using the program AFORM-RDC and take into account both RDC measurement uncertainty and 
local structural noise in the idealized A-form helix.[6] 
 
 Helix	   N	   RMSD (Hz)	   R	   η	   ϑ(x10
-3)	   ϑint	   β°	  
I 19 4.1 0.98 0.19±0.08 1.04±0.04 
E-TARGC 
II 12 3.2 0.98 0.16±0.10 1.06±0.10 
1.02±0.1 11.9±6.5 
I 13 1.9 0.99 0.36±0.21 1.89±0.21 
TARGC- 
ARG 








Figure S1. 2D CH and NH HSQC spectra of TAR (black), TARGC (orange) and TAR-ARG (purple) 
 
 
Figure S2. 2D CH and NH HSQC spectra of TARGC (black) and EI-TARGC (orange) demonstrating that elongation does not 
affect the structural and dynamical integrity of TARGC. Significant perturbations are primarily localized at residues near the 
site of elongation. 
 
 
Figure S3. Normalized resonance intensities measured in 2D HSQC spectra of EI-TAR, EI-TAR-ARG, and EI-TARGC.  




Figure S4. 2D CH and NH HSQC spectra of TAR (black), TARGC-ARG (green) and TAR-ARG (purple).  
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